HIGHLIGHTS
- who: Jose Manuel Dodero-Anillo et al. from the Clinical Pharmacology, Hospital Universitario Puerto Real, Puerto Real, Spain and, University of Cadiz, Cu00e1diz, Spain have published the article: Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis, in the Journal: Life 2022, 12, 2075. of /2022/
- what: Plasma determinations of drug and antidrug antibodies levels are an objective tool for optimisation in these patients; however established therapeutic ranges are not suitable so the objective of this study was to study these patients and optimise their healthcare. New ranges were found with higher sensitivity than . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.